학술논문
Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer
Document Type
Article
Author
Source
In: International Journal of Radiation Oncology Biology Physics . (International Journal of Radiation Oncology Biology Physics, 1 May 2022, 113(1):117-124)
Subject
Language
English
ISSN
1879355X
03603016
03603016